Clinical trial
Pirfenidone in Children and Young Adults With Neurofibromatosis Type I and…
NCT00076102 · National Cancer Institute (NCI), NIH · Completed
Key facts
| NCT number | NCT00076102 |
|---|---|
| Title | Pirfenidone in Children and Young Adults With Neurofibromatosis Type I and Progressive Plexiform Neurofibromas |
| Official title | Phase II Trial of Pirfenidone in Children, Adolescents, and Young Adults With Neurofibromatosis Type 1 and Progressive Plexiform Neurofibromas |
| Lead sponsor | National Cancer Institute (NCI), NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Neurofibromatosis 1, Neurofibroma, Plexiform |
| Intervention type | Drug |
| Interventions | Pirfenidone |
| Enrollment | 36 |
| Start date | Jul 21, 2004 |
| Primary completion | Apr 1, 2010 |
| Completion | Apr 1, 2010 |
| First posted | Jan 14, 2004 |
| Last update posted | Apr 23, 2018 |
| Countries | United States |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: